FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

1336821000168103: cannabidiol 5 mg / 1 mL + delta-9-tetrahydrocannabinol 20 mg / 1 mL oral oil, 50 mL (medicinal product pack)


Status: current, Defined. Date: 31-Jul 2019. Module: Australian Medicines Terminology module

Descriptions:

Id Description Lang Type Status Case? Module
3401501000168112 cannabidiol 5 mg / 1 mL + delta-9-tetrahydrocannabinol 20 mg / 1 mL oral oil, 50 mL (medicinal product pack) en Fully specified name Active Case sensitive Australian Medicines Terminology module
3401511000168110 delta-9-tetrahydrocannabinol 20 mg/mL + cannabidiol 5 mg/mL oral oil, 50 mL en Synonym Active Case sensitive Australian Medicines Terminology module


2 descendants. Search Descendants:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
delta-9-tetrahydrocannabinol 20 mg/mL + cannabidiol 5 mg/mL oral oil, 50 mL Is a medicinal product pack true Inferred relationship Some
delta-9-tetrahydrocannabinol 20 mg/mL + cannabidiol 5 mg/mL oral oil, 50 mL has MPUU delta-9-tetrahydrocannabinol 20 mg/mL + cannabidiol 5 mg/mL oral oil true Inferred relationship Some 1

Inbound Relationships Type Active Source Characteristic Refinability Group
LGP Classic 20:5 (THC:CBD) oral oil, 50 mL Is a True delta-9-tetrahydrocannabinol 20 mg/mL + cannabidiol 5 mg/mL oral oil, 50 mL Inferred relationship Some

Reference Sets

Schedule 8 medications reference set

Medicinal product pack reference set

Back to Start